Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion.

Source:http://linkedlifedata.com/resource/pubmed/id/17015749

J. Immunol. 2006 Oct 15 177 8 5612-22

Download in:

View as

General Info

PMID
17015749